Application of Nanoparticles in the Diagnosis of Gastrointestinal Diseases: A Complete Future Perspective
Ning-ning Yue,Hao-ming Xu,Jing Xu,Min-zheng Zhu,Yuan Zhang,Cheng-Mei Tian,Yu-qiang Nie,Jun Yao,Yu-jie Liang,De-feng Li,Li-sheng Wang
DOI: https://doi.org/10.2147/ijn.s413141
IF: 7.033
2023-07-27
International Journal of Nanomedicine
Abstract:Ning-ning Yue, 1 Hao-ming Xu, 2 Jing Xu, 2 Min-zheng Zhu, 3 Yuan Zhang, 4 Cheng-Mei Tian, 5 Yu-qiang Nie, 2 Jun Yao, 1 Yu-jie Liang, 6 De-feng Li, 1 Li-sheng Wang 1 1 Department of Gastroenterology, Shenzhen People's Hospital (the Second Clinical Medical College, Jinan University), Shenzhen, Guangdong, People's Republic of China; 2 Department of Gastroenterology and Hepatology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China; 3 Department of Gastroenterology and Hepatology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, People's Republic of China; 4 Department of Medical Administration, Huizhou Institute of Occupational Diseases Control and Prevention, Huizhou, Guangdong, People's Republic of China; 5 Department of Emergency, Shenzhen People's Hospital (the Second Clinical Medical College, Jinan University), Shenzhen, Guangdong, People's Republic of China; 6 Department of Child and Adolescent Psychiatry, Shenzhen Kangning Hospital, Shenzhen, Guangdong, People's Republic of China Correspondence: De-feng Li; Li-sheng Wang, Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), No. 1017, Dongmen North Road, Luohu District, Shenzhen, 518020, People's Republic of China, Tel +86 755 25533018, Email ; The diagnosis of gastrointestinal (GI) diseases currently relies primarily on invasive procedures like digestive endoscopy. However, these procedures can cause discomfort, respiratory issues, and bacterial infections in patients, both during and after the examination. In recent years, nanomedicine has emerged as a promising field, providing significant advancements in diagnostic techniques. Nanoprobes, in particular, offer distinct advantages, such as high specificity and sensitivity in detecting GI diseases. Integration of nanoprobes with advanced imaging techniques, such as nuclear magnetic resonance, optical fluorescence imaging, tomography, and optical correlation tomography, has significantly enhanced the detection capabilities for GI tumors and inflammatory bowel disease (IBD). This synergy enables early diagnosis and precise staging of GI disorders. Among the nanoparticles investigated for clinical applications, superparamagnetic iron oxide, quantum dots, single carbon nanotubes, and nanocages have emerged as extensively studied and utilized agents. This review aimed to provide insights into the potential applications of nanoparticles in modern imaging techniques, with a specific focus on their role in facilitating early and specific diagnosis of a range of GI disorders, including IBD and colorectal cancer (CRC). Additionally, we discussed the challenges associated with the implementation of nanotechnology-based GI diagnostics and explored future prospects for translation in this promising field. Graphical Keywords: nano-diagnostics, imaging, gastroenterology, gastrointestinal tumor, inflammatory bowel disease Graphical Gastrointestinal (GI) diseases, which primarily encompass GI tumors and inflammatory bowel diseases (IBD), have a significant impact on the well-being of millions of people worldwide. Colorectal cancer (CRC) is the third most commonly diagnosed cancer, yet it ranks as the second leading cause of cancer-related deaths globally, posing a significant threat to human health. 1 Additionally, IBD is a chronic and recurrent inflammatory disorder that includes ulcerative colitis (UC) and Crohn's disease (CD). Its incidence exceeds 0.3%, substantially increasing the risk of CRC. 2–4 Given the absence of characteristic early symptoms in GI diseases, most patients are diagnosed at advanced stages, which severely affects their treatment options and overall prognosis. Consequently, the significance of early diagnosis cannot be overstated. Currently, the standard diagnostic tools for GI diseases consist of endoscopy, ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Although endoscopy has improved diagnostic accuracy by enabling direct visualization of lesions, it is associated with various procedural complications, such as functional impairment, pain reactions, respiratory distress, and bacterial infections, both during and after the invasive procedure. 5 Additionally, US, CT, MRI, and PET are commonly employed for staging comparison and surgical evaluation of GI diseases. H -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology